Edico Genome Expands Intellectual Property Portfolio with an Additional Five Patents Issued for DRAGEN Platform

Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO, March 20, 2017 – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage... Read more

Canopy Biosciences Licenses Novel Gene Editing Technology from Washington University and Johns Hopkins University

Technology gives researchers unprecedented control over gene expression NEWS PROVIDED BY Canopy Biosciences 31 Mar, 2017, 08:00 ET ST. LOUIS, March 31, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC, an emerging provider of products and services for gene editing and personalized medicine, announced today that it has entered an exclusive licensing agreement with Washington University in... Read more

Edico Genome Expands Intellectual Property Portfolio with an Additional Five Patents Issued for DRAGEN Platform

Company Holds Largest IP Portfolio Encompassing Processor-Based Analysis of Next-Generation Sequencing Data SAN DIEGO, March 20, 2017 – Edico Genome, creator of the world’s first processor designed to analyze next-generation sequencing data, today announced the United States Patent and Trademark Office has issued an additional five, foundational patents surrounding the DRAGEN™ platform for analysis and storage... Read more

Bio-Techne Signs Exclusive License Agreement with Multiclonal Therapeutics for Adult “Ground-state” Stem Cell Technology

MINNEAPOLIS, Minnesota (March 7, 2017)- Bio-Techne has entered into an exclusive license agreement with Multiclonal Therapeutics (MCT) to commercialize reagents and media systems in the research reagent field intended for cloning, propagating, and differentiating adult “ground-state” stem cells from healthy and diseased epithelial tissues. Working together, Bio-Techne and MCT will transition this breakthrough technology into... Read more

908 Devices’ Commercialization of Oak Ridge National Laboratory Technology Honored with Federal Laboratory Consortium Award

03.06.17 Life Sciences, Applied Markets, Safety & Security 908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced that its efforts to develop, build and launch commercial products based on technology licensed from Oak Ridge National Laboratory (ORNL) have been honored by the Federal Laboratory Consortium for Technology Transfer as an... Read more

Abberior Instruments and Leica Microsystems conclude license agreement

Living T cell in suspension acquired with a Leica TCS SP8 STED 3X. 3D reconstruction of confocal and STED stacks clearly shows the gain in resolution by STED. Scale bar: 1 µm. Courtesy of Marco Fritsche, Mathias Clausen, and Christian Eggeling, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, UK. Goettingen... Read more